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The response of antibody-forming cells  to antigen provides an example of 
induced protein synthesis. Ribonucleic acid (RNA) has been implicated in the 
induction of this reaction in recent experiments. Extracts of macrophages from 
immunized animals, which  could be  inactivated by ribonuclease,  have  been 
found to initiate antibody formation in normal rabbit lymphoid cells  (2,  3). 
Campbell (4) has reported that small antigen fragments are coupled to RNA, 
and  that  these  complexes  possess  antigenic  activity.  RNA  extracted  from 
immunized lymphoid ceils has been reported also (5) to confer homotransplanta- 
fion immunity upon normal lymphoid ceils. 
The present studies suggest that, in addition to a role in the initiation of the 
immune response,  RNA  is required for  the production of antibody protein. 
The secondary immune response, which has been studied in these experiments, 
is characterized by two phases. Initially, there is lymphoid cellular prolifera- 
tion and differentiation with synthesis of deoxyribonucleic acid  (DNA)  (6). 
Subsequently, cellular proliferation decreases, and antibody synthesis becomes 
the predominant reaction  (7,  8).  By analogy to known protein-synthesizing 
systems, it may be presumed that the DNA formed during the proliferative 
phase transfers information for the formation of antibody protein to an RNA 
template. The latter, which has been referred to as messenger RNA (9),  has 
been shown to be relatively stable in the case of hemoglobin synthesis in the 
reticulocyte (10), or labile in the synthesis of induced enzymes in bacteria (11) 
and in mammals (12,  13). The participation of messenger RNA in antibody 
synthesis, and whether it is stable or rapidly turned over have been investigated 
in the present experiments. 
The antibiotic actinomycin D has been shown to block the synthesis of RNA 
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by a  highly selective binding to the deoxyguanosine residues of DNA  required 
as  template  for the function  of RNA  polymerase  (14-16).  In  the present  ex- 
periments,  the  effect of acfinomycin D  and  of several other potent  inhibitors 
of  nucleic  acid  and  protein  synthesis  on  RNA  and  antibody  formation  by 
anamnesfic rabbit lymphoid cells has been studied. Inhibition of the production 
of  antibody  to  T2  phage  by  actinomycin  D  has  recently  been  described  in  a 
preliminary  report  by  Uhr  (17). 
Materials and Methods 
Actinomycin D  (Lot No. 1687C-41A)  was obtained through the courtesy of the American 
Cyanamid Company, Research Division, Pearl River, New York.  L-Phenylalanine mustard 
(L-sarcolysin)  and hydroxyurea were made available by Dr. Eugene Frenkel of the Southwest 
Cancer Chemotherapy Group (United States Public Health Service). 
Preparation of Cdls.--Albino rabbits weighing approximately 2.5 kg were hyperimmunized 
by 18 triweekly injections of crystalline bovine serum albumin (BSA), given initially in com- 
plete Freund's adjuvant and later in alum-precipitated form. After a  rest period of 3 to 6 
months, these animals were injected with a total of 10 mg of BSA, given in divided doses into 
each foot-pad and the paravertebral musculature of the neck. One hour prior to injection, 
50 mg of promethazine hydrochloride was injected intramuscularly. Three days later (and in 
two experiments, 5 days later), the anti-BSA titer of the individual sera was checked by the 
ring precipitation test (18). If the serum demonstrated a trace or more of antibody, the rabbit 
was considered suitable for use. Sixty-five mg of pentobarbital was administered slowly intra- 
venously, and the animal bled to death by heart puncture. The spleen and lymph nodes were 
excised and minced in 10 ml of ice-cold Eagle's medium (19). The tissue mince was filtered 
through a nylon mesh gauze (7)  into sterile, chilled conical glass  centrifuge tubes. The cell 
suspension was then centrifuged in the cold at 1000 RP~ for 10 minutes, and the supernatant 
discarded. The packed  cells were resuspended in a  volume of Eagle's medium sufficient to 
bring the final cell concentration to approximately 100 million cells per ml. Initial cell viability 
using the trypan blue method (7) was approximately 90 per cent. 
Incubation  was carried out at 37°C in a water-saturated atmosphere, made up of 95 per 
cent air and 5 per cent COs in sterile, disposable, 30 ml plastic tissue culture flasks. The con- 
tents of each incubation flask are indicated in Table I. 
RNA Extraction Procedures.--Total  RNA was isolated at the end of incubation by adding 
3 ml of 0.5 per cent sodium dodecyl sulfate in Perry's buffer (20) to each incubation flask, and 
then  extracting  three  times with water-saturated  phenol  (21).  Ten mg of non-radioactive 
cytidine monophosphate (CMP) was added to the aqueous extract, and this was then dialyzed 
against 40 liters of 0.01 M phosphate buffer, pH 7. The dialyzed samples were then lyophilized 
and redissolved in 0.5 ml of 2 N NaOH. The resulting solution was then heated at 90°C for 30 
minutes to fragment the RNA. After cooling, the solution was diluted to 1 ml with water, 
and added to 10 ml of Bray's phosphor (22) for counting in a  Packard tricarb liquid scintilla- 
tion counter. 
RNA from the incubated samples was also fractionated according to the method of Yamana 
and Sibatini (23) as modified by Holland (24). Two ml of water-saturated phenol was added to 
the living cell mixture, and after shaking and centrifugation, the aqueous supernatant  and 
interface material were collected separately. The aqueous supernatant, which has been shown 
to contain most of the ribosomal and transfer RNA (25), was extracted twice more with an 
equal volume of water-saturated phenol. The supernatant  was then dialyzed following addi- 
tion of non-radioactive CMP, and prepared for radioactive counting as above. j.  DONALD SMILEY, JOHN  G.  HEARD~ AND  MORRIS ZIFF  883 
The precipitated interface material obtained above was resuspended in 2 ml of 0.5 per cent 
sodium dodecyl sulfate in Perry's buffer (20). Two ml of water-saturated phenol was then 
added, and the mixture shaken and centrifuged. The aqueous extract of the interface material, 
which has been shown to contain the rapidly labeled, presumably messenger  RNA fractions 
(26), was then dialyzed in the presence of CMP, lyophilized, dissolved, and counted as above. 
Sucrose  density gradient separation of RNA fractions was carried out by the method of 
Scherrer  and Darnell (27). 
Antibody Isotation.--At the end of a 6 hour incubation  period, 5 ml of normal rabbit serum 
was added to each sample. The contents of the flasks were then frozen and thawed three times 
by immersion in an alcohol-dry-ice bath, and dialyzed in size 20 Visking tubing for 36 hours 
in 40 liters of 0.01 ~  Na~HPO4 at 4°C. The samples were then spun at 100,000 g for 30 min- 
utes. The supernatant was then transferred to a  diethylaminoethyl (DEAE) cellulose column 
for isolation of 3'9.-globulin according to the method of LoSpalluto and coworkers  (28).  Re- 
maining protein adherent to the column  was eluted as a single fraction with 0.15 M NaH~PO4 
in 0.15 M NaC1 (28). The pooled fractions containing  3~-globulin  were lyophilized,  dissolved in 
TABLE I 
Contents of Incubation Flasks 
Material 
Lymphoid cells ...................................... 
Leucine-l-C  14 ....................................... 
HS-Cytidine monophosphate ......................... 
Penicillin G ........................................ 
Concentration per mI* 
40-50 million cells 
1.3-3.1 #c 
2.1-5.0#c 
6250 units 
* In Eagle's medium (19), made up without leucine for incorporation of leucine-l-C  14 and 
complete for incorporation of HS-cytidine  monophosphate. Final volume was 2 ml. 
3 ml of water, and clarified by centrifugation for 10 minutes at 25,000 g. To each sample was 
added a chromatographically separated preparation of non-radioactive  rabbit "/z-globulin (28) 
with a previously determined high titer of anti-BSA antibody, and containing approximately 
50 mg of protein per mi. An equivalent amount of BSA was then added to give a  total an- 
tigen-antibody precipitate of approximately 5 nag (29). The samples were incubated at 370C 
for 1 hour, cooled  overnight, and  centrifuged  at  25,000  g  for  10  minutes. The  antigen- 
antibody precipitateswere then dissolved in 0.5 N NaOH, heated in a boiling water bath for 10 
minutes, and added to 10 ml of Bray's phosphor (22) for counting. 
~S~TS 
Effect  of Actinomycin  D  on Anti-BSA  Syntkesis.--Incorporation  of  radio- 
activity into newly synthesized antibody by control cell suspensions was  ob- 
served  to  be  approximately  linear  up  to  6  hours.  Following addition  of  ac- 
tinomycin D,  an abrupt cessation of antibody synthesis occurred  after  about 
21~ hours (Fig.  1). 
Synthesis of antibody and RNA by lymphoid cells was studied as a  function 
of  the  concentration  of  actinomycin  D.  The  effect  of  preincubation  before 
addition of radioactive label was  also  examined.  Viability of untreated  cells, 884  RNA  SYNTHESIS AND  ANTIBODY ]~OI~ATION 
as measured by the trypan blue method (7), which was initially approximately 
90 per cent, declined to 50  to 60 per cent after 6 hours. Actinomycin D,  in 
concentrations up to 25/~g per ml, produced no difference in cell viability be- 
tween control and inhibited flasks. Above 1/zg per ml, increasing concentra- 
tions of acfinomycin D produced a progressive decrease in synthesis of anti-BSA 
(Fig. 2).  Above 25 #g per ml, a  further slight decrease in antibody synthesis 
was accompanied by a decrease in cell viability. 
Inhibition was more pronounced when actinomycin D was added 30 minutes 
prior to addition of radioactive label than when both were added at the same 
time, as is shown by comparison of the upper with the lower curve in Fig. 2. 
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FIG. 1. Incorporation  of radioactivity  into 7~-anti-BSA with and without actinomycin  D, 
20/~g/ml, added 30 minutes before L-leucine-l-C  14. 
Production d  non-anti-BSA 3%-globulin, and of other protein eluted from the 
DEAE cellulose column, fell under the influence of actinomycin D  in the same 
manner as that of anti-BSA (Fig. 3). In the non-inhibited control of this ex- 
periment, approximately 10 per cent, 30 per cent, and 60 per cent of the total 
counts were incorporated into 3'~-anti-BSA,  other non-anti-BSA  3'2-globulin, 
and  the  fraction containing other proteins  respectively. 
Mter  a  75 minute preincubation with actinomycin D,  replacement of the 
culture fluid with Eagle's medium, free of inhibitor, provided no release from 
inhibition, suggesting that the binding of actinomycin D, intracellularly, was 
not reversible. 
In the same experiments in which the effect of actinomycin D  on antibody 
synthesis was studied, parallel observations were made on the synthesis of RNA 
as measured by incorporation of I-I3-CMP (Table II).  It is seen that, in the 
absence of inhibitor, antibody-producing lymphoid cells  actively synthesized 
RNA. This was observed in cells removed both 3 days (Table II) and 5 days 885 
/40 
after antigen administration. At levels of 10 and 25 #g per ml, actinomycin D 
produced  marked inhibition of antibody synthesis and this was accompanied 
by an almost complete  suppression  of RNA synthesis.  It should be noted, 
however, that at a level of 1 #g per ml, marked inhibition of RNA synthesis 
occurred without a decrease in antibody synthesis. 
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FIG. 2.  Effect of actinomycin D  on synthesis of anti-BSA. The lower curve represents, at 
each point, an average of 6 experiments, in which there was a 30 minute period of preincuba- 
tion before the addition of leucine-l-C  14. The dotted line represents a stimulation of synthesis 
noted at 0.1/~g/m]. The upper curve represents a single experiment in which actinomydn D 
was added simultaneously with C14-1abel. Antibody synthesis is expressed as per cent of in- 
corporation observed in the non-inhibited control. 
In view of the above finding, it was decided to determine which type of RNA 
synthesis was sensitive to low concentrations of actinomycin D. This was done 
by two techniques. The first, illustrated in Fig. 4, shows the effect of actinomycin 
D on the synthesis of various fractions of RNA separated in a sucrose density 
gradient (27). The heavier RNA fractions are presumed  to be microsomal and 
messenger RNA, and the lighter fractions transfer RNA (27). It is seen that 
significant inhibition of the synthesis of all types of RNA was produced. 
The  second  technique,  the phenol  fractionation method of Holland  (24), 
was utilized  to prepare  a  supernatant fraction containing primarily transfer 886  RNA  SYNTHESIS  AND  ANTIBODY  FORMATION 
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FIG. 3.  Effect of actinomycin  D on various types of protein synthesized by a lymphoid cell 
suspension: O, BSA-anti-BSA  precipitate; A, non-anti-BSA 3"~-globulin; e, other protein 
eluted from DEAE cellulose column. 
TABLE II 
Effect of Actinomycin D on the Synthesis of R~A and Antibody 
Synthesis anfi-BSA,  RNA  Synthesis RNA, 
Actinomycin D  Ag-Ab ppt  per cent of control  per cent of control 
~*glml 
0 
1 
10 
25 
CPK 
220 
232 
116 
53 
100 
106 
53 
24 
CPM 
3432 
44O 
159 
22 
100 
13 
3 
1 
Ag-Ab ppt, antigen-antibody  precipitate. 
and ribosomal RNA (25),  and an interface fraction considered to be messenger 
RNA (26).  As can be seen in Table III, inhibition of the synthesis of all types 
of RNA again occurred. However, coincidentally with the moderate to marked 
inhibition of RNA synthesis by actinomycin D observed at levels of 1 ~g/ml or 
less,  there  was  actually an  increase  in  synthesis of antibody.  Thus,  in  both 
experiments,  there was, at low concentrations of actinomycin D, a  dichotomy 
of effect on RNA and antibody synthesis. This consisted of either  no change J.  DONALD SMILEY~ JOHN  G.  HEARD~ AND  MORRIS  ZLFF  887 
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FIG.  4.  Effect of actinomycin D  on synthesis of various fractions of RNA separated in 
sucrose density gradient: O, total RNA as measured spectrophotometrically at 260 m/z, A, 
cp~a in RNA of non-inhibited control cells;  @, cP•  in RNA of cells exposed to 1/zg/ml of 
actinomycin D. 
TABLE  III 
Effect  of Actinomycin D on the Synthesis of Antibody and RNA Fractions 
Synthesis as per cent of control 
Actinomycin D  RNA fractions 
ag/ml 
0.1 
1.0 
5.0 
10.0 
Anti-BSA 
148 
128 
51 
41 
Supernatant* 
58 
20 
8 
4 
Interfaces 
71 
17 
6 
2 
* Ribosomal and transfer RNA.  (These comprise 90 per cent of total RNA.) 
Rapidly labeled, presumably messenger RNA (10 per cent of total). 888  RNA  SYNTHESIS  AND  ANTIBODY  FORMATION 
TABLE  IV 
Effect of Puromycin,  Hydroxyurea,  L-Phenylalanine  Mustard,  and  6-Mercaptopurine 
on Synthesis of Anti-BSA 
Puromycin, mmoles/ml ....................... 
Per cent of control ........................ 
Hydroxyurea, mg/ml ......................... 
Per cent of control ........................ 
L-Phenylalanine  mustard, #g/ml .............. 
Per cent of control ........................ 
6-Mercaptopurine, I~g/ ml ..................... 
Per cent of control ........................ 
10-  8 
9 
3.0 
61 
40 
37 
400 
91 
10-4 
16 
0.3 
78 
20 
73 
200 
96 
10-5 
82 
0.03 
92 
2 
102 
20 
91 
or even a significant increase in antibody formation in the presence of a marked 
decrease in synthesis of RNA. 
Effect of Other Inhibitors.--Puromycin  (Table IV), which is known to affect 
protein synthesis at the level of transfer RNA (30), caused marked suppression 
of antibody formation. This is in agreement with a recent report of Ambrose and 
Coons  (31).  Hydroxyurea and  L-phenylalanine  mustard,  substances believed 
to affect synthesis of DNA, suppressed antibody formation only at high  con- 
centrations,  well above those reached therapeutically in man (32, 33).  6-Mer- 
captopurine (6-MP) had no significant  effect in this system, even at very high 
concentrations. 
DISCUSSION 
Actinomycin D  produced marked  suppression  of antibody synthesis,  even 
at moderately low concentrations. This agent has been shown to have a highly 
selective action,  the inhibition  of DNA-dependent RNA synthesis,  including 
the synthesis of messenger  RNA (14-15).  Mitchell and Nossal (34) have re- 
ported that plasma cells engaged  in the secondary antibody response  did not 
incorporate significant amounts of I-P-uridine, as measured by radioautography, 
and, therefore,  were presumably not synthesizing  messenger  RNA. They sug- 
gested on the basis of this finding  that  the messenger  RNA responsible  for 
continued antibody synthesis in the anamnestic lymphoid cell was completely 
stable, and perhaps even contributed by a parent cell. The present observation 
that Hs-CMP was incorporated into chemically  isolated RNA both 3  and  5 
days after antigenic stimulation indicates that new synthesis of RNA does oc- 
cur during this  period of  most  rapid  antibody  formation.  However, in  the 
present mixed cell population, it is not certain what fraction of this  synthesis 
is contributed by antibody-producing cells. Recently published observations of J.  DONALD  SMILEY, JOHN G. HEARD, AND MORRIS ZII~"  889 
the suppression of antibody synthesis by actinomycin D  in an in vitro  culture 
of secondarily stimulated lymphoid cells  have led Uhr (17)  to suggest  that 
this suppression was a consequence of inhibition of the synthesis of messenger 
RNA. 
The  abrupt  cessation  of  antibody synthesis observed  approximately 2.5 
hours after addition of actinomycin D at a concentration of 20 gg/ml (Fig. 1) 
suggests  that the messenger RNA in this system has a finite stability. This 
observation is analogous to that of Levinthal and coworkers (35) on the effect 
of actinomycin D on protein synthesis in Bacillus subtilis, in which the mean 
life of messenger RNA was estimated as approximately 2 minutes. 
The observation  that antibody production may continue when RNA syn- 
thesis is markedly inhibited indicates that the relationship  of messenger RNA 
to antibody synthesis is a complex one. Thus, when the synthesis  of various 
RNA fractions,  isolated  by sucrose density gradient or supernatant-interface 
phenol  fractionation, was  measured,  it was found that the formation of all 
fractions of RNA, including the portion believed to contain messenger RNA, 
was  markedly inhibited at  actinomycin concentrations  which  produced  no 
decrease in antibody synthesis. This suggests that the level of messenger RNA 
may not be the limiting factor in the series of reactions involved in the forma- 
tion  of  antibody,  and  that antibody production is  inhibited  only  when  a 
relatively stable messenger RNA fraction is reduced  in concentrations below 
a critical level by an almost total inhibition of new synthesis. 
The simultaneous suppression of protein synthesis other than that of ~/2-anti- 
BSA by actinomycin D represents  inhibition of formation of other antibodies 
and  of  non-antibody protein  associated  with  lymphoid cell  function.  It  is 
reasonable that the synthesis of other ~t2-globulin should be equally susceptible 
to suppression by actinomycin D. The observed decreased synthesis of non-3%- 
globulin  protein has several  possible explanations.  A portion of this protein 
may consist of 5'1 A- and ")'1  M-immunoglobulin, the synthesis of which might be 
susceptible to the effect of actinomycin D in the same manner as 3,~-globulin. 
It is also possible that protein synthesis  generally is suppressed  in the anti- 
genically stimulated lymphoid ce]l in a uniform manner by actinomycin, either 
by a similar effect on all types of messenger RNA or by a selective effect on 
the messenger RNA required  for the synthesis of a critical cell constituent. 
The increase in antibody production noted at low levels of actinomycin D 
is difficult to explain. It may result from suppression of competitive phenomena, 
which are relatively more sensitive to low concentrations  of the drug. Indeed, 
Perry (20) has shown selective inhibition by very low levels of actinomycin 
D of nucleolar RNA synthesis, believed to be primarily ribosomal RNA, with 
very little effect on other nuclear RNA synthesis. 
The inhibition produced by actinomycin D could not be reversed by removal 
of the cells to an inhibitor-free medium, possibly because the drug is irreversibly 890  RNA  SYNTHESIS  AND  ANTIBODY  FORMATION 
bound to the DNA of the cells. This would be in agreement with the findings 
of Paul and Struthers (36) in L cell fibroblasts inhibited by actinomycin D. 
It should be noted that the present experiments have utilized a  whole cell 
suspension to investigate the relationship of RNA synthesis to antibody syn- 
thesis in the presence of inhibitors. Although the RNA of the intact cell  is 
associated with the formation of a variety of proteins,  it is reasonable to as- 
sume that new RNA synthesis in lymphoid cells forming antibody at a maxi- 
mum rate is primarily related to the production of gamma globulin. Inhibition 
of antibody production, however, could be the result of the suppression of the 
synthesis  of  unrelated  messenger  RNA  necessary for  the  formation  of  an 
essential cell  constituent and not antibody. Such a  constituent might be an 
enzyme necessary either for protein synthesis or for the continued viability of 
the cell. The fact that normal amounts of antibody were produced by cells in 
which RNA synthesis had been reduced by actinomycin D  to 17 per cent of 
the control value suggests that the cells were still viable at a time when RNA 
synthesis had  been  inhibited  to  a  considerable  extent.  However,  at  higher 
levels of inhibition, staining with trypan blue (7), may not be fully satisfactory 
as a measure of cell viability. 
6-Mercaptopurine has been shown to inhibit the conversion of inosinic to 
xanthylic acid, thus blocking guanine biosynthesis (37).  It would be expected, 
therefore, that this agent would affect both DNA and RNA biosynthesis. In 
the present studies,  no significant effect of 6-MP  on the synthesis of either 
RNA or antibody was observed during the 6 hour period of incubation. This 
result could reflect a  relatively slow onset of inhibition of guanine synthesis, 
perhaps  because of cell  permeability barriers  to 6-MP,  or the presence of a 
relatively large pool of available purines within the cell which could sustain 
nucleic acid synthesis during the time period involved. It is also possible that 
6-MP  affects DNA  synthesis primarily,  and  would,  therefore,  be  relatively 
ineffective in a resting cell suspension such as the one utilized. The latter pos- 
sibility is supported by the observations of ~terzl (38) and Schwartz and co- 
workers  (39),  who were unable to block antibody synthesis in intact rabbits 
once the secondary response was underway. 
Puromycin has  been  shown  to  have  no  effect on  RNA  synthesis, but is 
thought to inhibit the final step in protein synthesis, in which amino acids 
attached to transfer RNA are condensed to form protein (30).  In the present 
experiments, puromycin strongly inhibited antibody formation, offering further 
evidence that antibody synthesis follows the classic pathways of protein syn- 
thesis. Similar observations have recently been reported by Ambrose and Coons 
(31).  Hydroxynrea and L-phenylalanine mustard inhibited antibody produc- 
tion only in relatively high concentrations, well above  those reached in the 
intact organism (32, 33). Although the exact site of action of these compounds 
has not been elucidated, they are believed to affect DNA synthesis. J. DONALD  SMILEY, JOHN G. HEARD, AND ~[ORRIS ZI_FF  891 
Previous studies, both in vitro and in vivo, have shown inhibition of antibody 
formation during the proliferative phase of the secondary response by agents 
like 5-bromodeoxyuridine (40, 41) and methotrexate (42), which are thought to 
act on the synthesis of DNA. The present results have demonstrated inhibition 
of antibody synthesis at two other significant sites,  that  is,  the synthesis of 
RNA and the coupling of amino acids. The above findings, taken together, are 
consistent with the view that antibody synthesis, although an induced form 
of protein synthesis, follows pathways similar to those utilized for other types 
of protein. 
SUMMARY 
Antibody synthesis in  anamnestic lymphoid cells,  measured by incorpora- 
tion of leucine-C  14 into specific antibody, was inhibited at moderate concentra- 
tions of actinomycin D. This was accompanied by marked inhibition of syn- 
thesis of RNA as measured by incorporation of HS-cytidine monophosphate. 
However,  at  low  concentrations  of actinomycin D,  antibody synthesis  was 
unaffected or even increased while RNA synthesis continued to be inhibited. 
The  results  obtained  suggest  that  messenger  RNA  for  antibody  synthesis, 
either because it is relatively stable or present in excess, does not become a 
limiting factor until its synthesis is maximally inhibited. 
Puromycin,  an  inhibitor  of amino  acid  coupling,  abolished  antibody syn- 
thesis in low concentration. 6-Mercaptopurine had no effect on the synthesis 
of antibody or RNA even at high concentration. 
The data obtained support the view that antibody synthesis follows path- 
ways similar to those utilized for the formation of other types of proteins. 
The authors wish to express  their appreciation to Dr. Hugo E. 3asin for his help in the de- 
velopment of the conditions of cell incubation and antibody isolation, and to Miss Helen 
Horton for valuable technical assistance. 
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